drugset / Trial / NCT00815607
Trial of an Intratumoral Injections of INXN-3001 in Subjects With Stage III or IV Melanoma
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to test the safety of an investigational combination drug/immunotherapy for the treatment of Stage III/IV melanoma.
Timeline
- Start
- 2009-04
- Primary completion
- 2013-01
- Completion
- 2013-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | INXN-3001 | Cell therapy | — | Other |
| Subject | veledimex | Small molecule | — | Oral |